标题
Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
作者
关键词
-
出版物
BIOINORGANIC CHEMISTRY AND APPLICATIONS
Volume 2018, Issue -, Pages 1-18
出版商
Hindawi Limited
发表日期
2018-10-02
DOI
10.1155/2018/8276139
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug
- (2018) Keefe Guang Zhi Lee et al. ChemMedChem
- Dual-targeting antitumor hybrids derived from Pt(IV) species and millepachine analogues
- (2018) Xiaochao Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Theranostic Pt(IV) Conjugate with Target Selectivity for Androgen Receptor
- (2018) Xiaodong Qin et al. INORGANIC CHEMISTRY
- Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria
- (2018) Hong Chen et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Conjugation of platinum(IV) complexes with chlorambucil to overcome cisplatin resistance via a “joint action” mode toward DNA
- (2017) Xiaodong Qin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo
- (2017) Jing Ma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance
- (2017) Weiwei Hu et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs?
- (2017) Mauro Ravera et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Biotinylated platinum(IV) complexes designed to target cancer cells
- (2017) Jian Zhao et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Antitumor platinum(IV) derivatives of carboplatin and the histone deacetylase inhibitor 4-phenylbutyric acid
- (2017) Awatif Rashed Z. Almotairy et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery
- (2017) Jing Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hybrid of DNA-targeting Chlorambucil with Pt(IV) Species to Reverse Drug Resistance
- (2017) Feihong Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Inflammasomes in Inflammation-Induced Cancer
- (2017) Chu Lin et al. Frontiers in Immunology
- A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance
- (2016) Zhigang Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia
- (2016) Wen Lv et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Trans-platinum(II)/(IV) Complexes with Acetylpyridine Ligands as Antivascular Agents in vitro: Cytotoxic and Antiangiogenic Potential
- (2016) Filipovi| Lana et al. Anti-Cancer Agents in Medicinal Chemistry
- Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action
- (2016) Xiaochao Huang et al. BIOCONJUGATE CHEMISTRY
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Platinum(iv) anticancer prodrugs – hypotheses and facts
- (2016) Dan Gibson DALTON TRANSACTIONS
- Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects
- (2016) Jing Ma et al. DALTON TRANSACTIONS
- Insights into the anti-angiogenic properties of phosphaplatins
- (2016) Lu Yang et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin
- (2016) Juraj Zajac et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with ‘humanized’ antigen presentation as a new preclinical study tool
- (2016) Niels A. W. Lemmermann et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
- (2016) Raji Raveendran et al. Chemical Science
- The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression
- (2016) Jiandong Chen Cold Spring Harbor Perspectives in Medicine
- A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases
- (2015) Jana Kasparkova et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
- (2015) Vojtech Novohradsky et al. BIOCHEMICAL PHARMACOLOGY
- Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(iv) prodrug with unique mode of action
- (2015) Lili Ma et al. CHEMICAL COMMUNICATIONS
- An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: synthesis and photoactivation studies
- (2015) Albert Gandioso et al. CHEMICAL COMMUNICATIONS
- Is glutamine deficiency the link between inflammation, malnutrition, and fatigue in cancer patients?
- (2015) Marcus Schlemmer et al. CLINICAL NUTRITION
- Integrin-targeted delivery into cancer cells of a Pt(iv) pro-drug through conjugation to RGD-containing peptides
- (2015) Anna Massaguer et al. DALTON TRANSACTIONS
- Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity
- (2015) Alexey A. Nazarov et al. DALTON TRANSACTIONS
- The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells
- (2015) TOMAS GROH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery
- (2015) Franco M. Muggia et al. JOURNAL OF CLINICAL ONCOLOGY
- Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules
- (2015) Min Soo Kim et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
- (2015) Samuel G. Awuah et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Cancer: Mitochondrial Origins
- (2015) George B. Stefano et al. MEDICAL SCIENCE MONITOR
- Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
- (2014) Daniel Yuan Qiang Wong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
- (2014) Rakesh K. Pathak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
- (2014) Qinqin Cheng et al. CHEMICAL COMMUNICATIONS
- Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
- (2014) Joshua Ko et al. CURRENT MEDICINAL CHEMISTRY
- Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one
- (2014) Elisabetta Gabano et al. DALTON TRANSACTIONS
- Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
- (2014) Vojtech Novohradsky et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Reprogramming the Mechanism of Action of Chlorambucil by Coupling to a G-Quadruplex Ligand
- (2014) Marco Di Antonio et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide
- (2014) Mathias Gehrmann et al. PLoS One
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Conjugation of vitamin E analog α-TOS to Pt(iv) complexes for dual-targeting anticancer therapy
- (2013) Kogularamanan Suntharalingam et al. CHEMICAL COMMUNICATIONS
- Glutamine and cancer: cell biology, physiology, and clinical opportunities
- (2013) Christopher T. Hensley et al. JOURNAL OF CLINICAL INVESTIGATION
- Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells
- (2013) Manuela Alessio et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- A Selective Mitochondrial-Targeted Chlorambucil with Remarkable Cytotoxicity in Breast and Pancreatic Cancers
- (2013) Melissa Millard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effects of light-activated diazido-PtIV complexes on cancer cells in vitro
- (2013) P. J. Bednarski et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES
- αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
- (2012) Nora Graf et al. ACS Nano
- Expression of glucose transporters in cancers
- (2012) Leszek Szablewski BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells
- (2012) Nora Graf et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Suberoyl bishydroxamic acid-induced apoptosis in HeLa cells via ROS-independent, GSH-dependent manner
- (2012) Bo Ra You et al. MOLECULAR BIOLOGY REPORTS
- RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
- (2012) Fabienne Danhier et al. MOLECULAR PHARMACEUTICS
- Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
- (2012) Jun Yang et al. MOLECULAR PHARMACEUTICS
- Studies of Glutathione Transferase P1-1 Bound to a Platinum(IV)-Based Anticancer Compound Reveal the Molecular Basis of Its Activation
- (2011) Lorien J. Parker et al. CHEMISTRY-A EUROPEAN JOURNAL
- Evaluation of Platinum-Ethacrynic Acid Conjugates in the Treatment of Mesothelioma
- (2011) Ilaria Zanellato et al. ChemMedChem
- The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells
- (2011) Ke Long Jin et al. Journal of Gynecologic Oncology
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- T Cell Ig and Mucin Domain Proteins and Immunity
- (2010) L. P. Kane JOURNAL OF IMMUNOLOGY
- Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes
- (2010) Michael R. Reithofer et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma
- (2009) A Rocca et al. BRITISH JOURNAL OF CANCER
- Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells
- (2009) Hideharu Tatebe et al. CANCER LETTERS
- A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity
- (2009) Darren Griffith et al. CHEMICAL COMMUNICATIONS
- Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC
- (2009) P. Munster et al. CLINICAL CANCER RESEARCH
- Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma
- (2009) F. Vandermeers et al. CLINICAL CANCER RESEARCH
- From signaling pathways to microtubule dynamics: the key players
- (2009) Sandrine Etienne-Manneville CURRENT OPINION IN CELL BIOLOGY
- Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting
- (2009) Katherine S. Lovejoy et al. DALTON TRANSACTIONS
- Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects
- (2009) Kamala Kesavan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
- (2009) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
- (2008) Sanjeev Shangary et al. Annual Review of Pharmacology and Toxicology
- Systemic Treatments for Mesothelioma: Standard and Novel
- (2008) Hedy Lee Kindler CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Suberoyl Bis-Hydroxamic Acid Activates Notch-1 Signaling and Induces Apoptosis in Medullary Thyroid Carcinoma Cells
- (2008) L. Ning et al. ONCOLOGIST
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
- (2007) Sumitra Mukhopadhyay et al. BIOCONJUGATE CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now